课题基金 / 基金详情

The 1918 HA and NA: Antigens and Virulence Factors

The 1918 HA and NA: Antigens and Virulence Factors
1918 HA 和 NA:抗原和毒力因子
批准号:
6747481
负责人:
Christopher F Basler
金额:
$24.53万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2008-08-31

项目摘要

项目成果

Christopher F Basler的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project 3, The 1918 HA and NA: Antigens and Virulence Factors, seeks to use a combination of reverse genetics, molecular biological, biochemical and serological assays to further our understanding of the contributions at the molecular level, of the HA and NA proteins of the 1918 virus in virulence, and to assess the antigenic novelty of the 1918 surface glycoproteins. Preliminary data suggest that the 1918 HA and NA confer a high virulence phenotype upon influenza viruses in mice Tumpey, et al. (2002) PNAS 99, 13849-54. This project will evaluate the hypothesis that the high mortality rate of the 1918 pandemic was influenced both by the existence of an immunologically naive human population and by additional properties of the 1918 virus HA and NA. Pathogenesis studies of recombinant viruses containing 1918 HA and NA genes will be conducted in mice and chickens and will further evaluate the role of these proteins in virulence. In addition, Dr. Basler's laboratory will be reconstructing genes of the 1918 genes according to the sequences generated by Dr. Taubenberger. These reconstructed genes will be used by the different projects of the program project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibitors of SARS-CoV-2 Polymerase
  • 批准号:
    10514325
  • 项目类别:
  • 资助金额:
    $435.32万
  • 财政年份:
    2022
  • 负责人:
    Christopher F Basler
  • 依托单位:
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
  • 批准号:
    10289173
  • 项目类别:
  • 资助金额:
    $0.54万
  • 财政年份:
    2021
  • 负责人:
    Christopher F Basler
  • 依托单位:
VPS34 inhibitors as SARS-CoV-2 antivirals
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
国内基金
海外基金
小胶质细胞的IL-6/JAK/STAT3/MCP-1信号途径在MS/EAE发病过程中的作用
  • 批准号:
    81070958
  • 项目类别:
    面上项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2010
  • 负责人:
    程琦
  • 依托单位: